Protein Supplementation in Elderly With Sarcopenic Obesity Undergoing Caloric Restriction and Exercise
NCT ID: NCT04981366
Last Updated: 2025-06-13
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
105 participants
INTERVENTIONAL
2021-08-01
2023-08-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Lifestyle Modifications for the Treatment of Sarcopenic Obesity
NCT02379026
Nutritional Supplementation in Sarcopenic Obesity
NCT05143398
Whey Protein Supplementation and Resistance Training in Older Women With Sarcopenic Obesity.
NCT03752359
Protein Supplementation: Body Composition, Muscle Strength and Postural Balance
NCT03792646
The Nutritionist's Educational Intervention on the Protein Intake in Hospitalized Elderly People
NCT05502445
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Lifestyle interventions such as caloric restriction and exercise training are effective nonpharmacological strategies to mitigate some adverse effects related to this condition. Also, protein supplementation may boost the benefits of exercise, but this assumption is still to be tested. This trial aims to test whether protein supplementation is able to increase the benefits of exercise training in the elderly with sarcopenic obesity undergoing caloric restriction.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group (CTRL)
Patients allocated to this arm will not receive any intervention.
No interventions assigned to this group
Caloric Restriction associated to exercise training plus protein supplementation (CREX+PTN)
Patients allocated to this arm will be submitted to caloric restriction associated with exercise training program plus protein supplementation.
Protein supplement
40g of whey protein in the breakfast;
Caloric Restriction associated to exercise training plus isocaloric placebo (CREX+PLA)
Patients allocated to this arm will be submitted to caloric restriction associated with exercise training program plus isocaloric placebo.
isocaloric supplement
42g of isocaloric supplement in the breakfast;
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Protein supplement
40g of whey protein in the breakfast;
isocaloric supplement
42g of isocaloric supplement in the breakfast;
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body mass index (BMI) \> 30 kg/m2;
* Sarcopenia;
* not engage into exercise training programas.
Exclusion Criteria
* cognitive deficit or dementia that impossibility the patient to read and sign the informed consent form;
* any disease that limits participation in exercise training program.
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Sao Paulo General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hamilton Augusto Roschel da Silva
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hamilton Roschel, Phd
Role: PRINCIPAL_INVESTIGATOR
University of Sao Paulo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Sao Paulo
São Paulo, , Brazil
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
04234918.1.0000.0065
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.